Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DSG1 antisense RNA 1 is a long noncoding antisense RNA transcribed from the region opposite to the DSG1 gene. Antisense RNAs typically regulate gene expression of their sense counterparts through mechanisms including transcriptional interference or modulation of mRNA stability[4]. While some antisense RNAs serve important disease or developmental functions, there is currently no evidence that DSG1-AS1 is involved in disease pathology or is a therapeutic target. Most research and clinical interest regarding DSG1 focuses on the desmoglein-1 protein, a critical component of epidermal cell adhesion, differentiation, and disease, whereas DSG1-AS1 itself is not well characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DSG1 antisense RNA 1 (DSG1-AS1).